A Phase II Study of Flumatinib with Chemotherapy for Newly Diagnosed Ph/Bcr-Abl1- Positive Acute Lymphoblastic Leukemia in Adults
Latest Information Update: 01 Aug 2023
At a glance
- Drugs Flumbatinib (Primary) ; Idarubicin; Prednisone; Vincristine
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms Rj-All2020.2A trial
Most Recent Events
- 01 Aug 2023 New trial record
- 15 Jun 2023 Updated Results assessing efficacy and safety of Flumatinib with Chemotherapy for Newly Diagnosed Ph/Bcr-Abl1- Positive Acute Lymphoblastic Leukemia presented at the 28th Congress of the European Haematology Association